Global Pharmaceutical Starch Market Size, Share, Trends and Forecast 2022-2030

Description

Pharmaceutical Starch is an abundantly available natural resource and preferred excipient for drug delivery systems in pharmaceutical solid dosage forms. It is commonly used as a filler, binder, or coating in the drug manufacturing industry.
Industry Insights

Due to the COVID-19 pandemic, the global Pharmaceutical Starch market size is estimated to be worth US$ 1127.4 million in 2021 and is forecast to a readjusted size of US$ 1820.4 million by 2028 with a CAGR of 7.0% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Pharmaceutical Starch market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Pharmaceutical Starch landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

There are many players in the market, Tereos, Cargill, Roquette, Visco Starch, Colorcon and others are playing important roles in Pharmaceutical Starch industry. Top 5 players occupied about 15.29% market revenue share in 2019, The market is not concentrated for now and is still to be dispersed.

Pharmaceutical starch is widely used as a binding and disintegrating agent for tablets, pills and granules, also used as filler for capsules. By application, Tablets is the largest consumer group, with consumption market share of 57.1% in 2019. Then followed by the Capsule which account for 22.3%.

There are many different types of Pharmaceutical Starch. Based on the major consumption types, the market can be segmented into: Corn Starch, Potato Starch and Others. Corn Starch is the most commonly used types and took 90.7% market share in 2019, while Potato Starch took 6.8% market share and Other types took 2.5% in 2019.

As for consumption market, revenue of Pharmaceutical Starch in United States took about 30.1% market share in 2019, which is the biggest consumption country in current market pattern. China ranks the second largest consumption country, with market share of 9.7% in 2019.

This report focuses on Pharmaceutical Starch volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Pharmaceutical Starch market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: China, India, North America and Europe, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Pharmaceutical Starch market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Corn Starch

Potato Starch

Others

Segment by Application

Tablets

Capsule

Granular Formulation

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Tereos

Cargill

Roquette

Visco Starch

Colorcon

Agrana

Paramesu Biotech

Shandong Liaocheng E Hua Pharmaceutical

SPAC Starch Products (India) Limited

Sanstar Biopolymers Ltd

Ingredion

Shandong Liujia

Universal Starch-Chem Allied Ltd

Hunan Er-Kang Pharmaceutical

Jiangxi Yipusheng Pharmaceutical

Shanxi Mr G Pharmaceutical

Shivangan Food & Pharma

Splenor Starch LLP

Weifang Shengtai Medicine

Taishan Jinantang

Anhui Sunhere Pharmaceutical Excipients

TABLE OF CONTENT

1 Pharmaceutical Starch Market Overview
1.1 Product Overview and Scope of Pharmaceutical Starch

1.2 Pharmaceutical Starch Segment by Type

1.2.1 Global Pharmaceutical Starch Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Corn Starch

1.2.3 Potato Starch

1.2.4 Others

1.3 Pharmaceutical Starch Segment by Application

1.3.1 Global Pharmaceutical Starch Sales Comparison by Application: (2022-2028)

1.3.2 Tablets

1.3.3 Capsule

1.3.4 Granular Formulation

1.3.5 Others

1.4 Global Pharmaceutical Starch Market Size Estimates and Forecasts

1.4.1 Global Pharmaceutical Starch Revenue 2017-2028

1.4.2 Global Pharmaceutical Starch Sales 2017-2028

1.4.3 Pharmaceutical Starch Market Size by Region: 2017 Versus 2021 Versus 2028

2 Pharmaceutical Starch Market Competition by Manufacturers

2.1 Global Pharmaceutical Starch Sales Market Share by Manufacturers (2017-2022)

2.2 Global Pharmaceutical Starch Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Pharmaceutical Starch Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Pharmaceutical Starch Manufacturing Sites, Area Served, Product Type

2.5 Pharmaceutical Starch Market Competitive Situation and Trends

2.5.1 Pharmaceutical Starch Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Pharmaceutical Starch Players Market Share by Revenue

2.5.3 Global Pharmaceutical Starch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pharmaceutical Starch Retrospective Market Scenario by Region

3.1 Global Pharmaceutical Starch Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Pharmaceutical Starch Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Pharmaceutical Starch Market Facts & Figures by Country

3.3.1 North America Pharmaceutical Starch Sales by Country

3.3.2 North America Pharmaceutical Starch Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Pharmaceutical Starch Market Facts & Figures by Country

3.4.1 Europe Pharmaceutical Starch Sales by Country

3.4.2 Europe Pharmaceutical Starch Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Pharmaceutical Starch Market Facts & Figures by Region

3.5.1 Asia Pacific Pharmaceutical Starch Sales by Region

3.5.2 Asia Pacific Pharmaceutical Starch Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Pharmaceutical Starch Market Facts & Figures by Country

3.6.1 Latin America Pharmaceutical Starch Sales by Country

3.6.2 Latin America Pharmaceutical Starch Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Pharmaceutical Starch Market Facts & Figures by Country

3.7.1 Middle East and Africa Pharmaceutical Starch Sales by Country

3.7.2 Middle East and Africa Pharmaceutical Starch Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Pharmaceutical Starch Historic Market Analysis by Type

4.1 Global Pharmaceutical Starch Sales Market Share by Type (2017-2022)

4.2 Global Pharmaceutical Starch Revenue Market Share by Type (2017-2022)

4.3 Global Pharmaceutical Starch Price by Type (2017-2022)

5 Global Pharmaceutical Starch Historic Market Analysis by Application

5.1 Global Pharmaceutical Starch Sales Market Share by Application (2017-2022)

5.2 Global Pharmaceutical Starch Revenue Market Share by Application (2017-2022)

5.3 Global Pharmaceutical Starch Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Tereos

6.1.1 Tereos Corporation Information

6.1.2 Tereos Description and Business Overview

6.1.3 Tereos Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Tereos Pharmaceutical Starch Product Portfolio

6.1.5 Tereos Recent Developments/Updates

6.2 Cargill

6.2.1 Cargill Corporation Information

6.2.2 Cargill Description and Business Overview

6.2.3 Cargill Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Cargill Pharmaceutical Starch Product Portfolio

6.2.5 Cargill Recent Developments/Updates

6.3 Roquette

6.3.1 Roquette Corporation Information

6.3.2 Roquette Description and Business Overview

6.3.3 Roquette Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Roquette Pharmaceutical Starch Product Portfolio

6.3.5 Roquette Recent Developments/Updates

6.4 Visco Starch

6.4.1 Visco Starch Corporation Information

6.4.2 Visco Starch Description and Business Overview

6.4.3 Visco Starch Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Visco Starch Pharmaceutical Starch Product Portfolio

6.4.5 Visco Starch Recent Developments/Updates

6.5 Colorcon

6.5.1 Colorcon Corporation Information

6.5.2 Colorcon Description and Business Overview

6.5.3 Colorcon Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Colorcon Pharmaceutical Starch Product Portfolio

6.5.5 Colorcon Recent Developments/Updates

6.6 Agrana

6.6.1 Agrana Corporation Information

6.6.2 Agrana Description and Business Overview

6.6.3 Agrana Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Agrana Pharmaceutical Starch Product Portfolio

6.6.5 Agrana Recent Developments/Updates

6.7 Paramesu Biotech

6.6.1 Paramesu Biotech Corporation Information

6.6.2 Paramesu Biotech Description and Business Overview

6.6.3 Paramesu Biotech Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Paramesu Biotech Pharmaceutical Starch Product Portfolio

6.7.5 Paramesu Biotech Recent Developments/Updates

6.8 Shandong Liaocheng E Hua Pharmaceutical

6.8.1 Shandong Liaocheng E Hua Pharmaceutical Corporation Information

6.8.2 Shandong Liaocheng E Hua Pharmaceutical Description and Business Overview

6.8.3 Shandong Liaocheng E Hua Pharmaceutical Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Shandong Liaocheng E Hua Pharmaceutical Pharmaceutical Starch Product Portfolio

6.8.5 Shandong Liaocheng E Hua Pharmaceutical Recent Developments/Updates

6.9 SPAC Starch Products (India) Limited

6.9.1 SPAC Starch Products (India) Limited Corporation Information

6.9.2 SPAC Starch Products (India) Limited Description and Business Overview

6.9.3 SPAC Starch Products (India) Limited Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.9.4 SPAC Starch Products (India) Limited Pharmaceutical Starch Product Portfolio

6.9.5 SPAC Starch Products (India) Limited Recent Developments/Updates

6.10 Sanstar Biopolymers Ltd

6.10.1 Sanstar Biopolymers Ltd Corporation Information

6.10.2 Sanstar Biopolymers Ltd Description and Business Overview

6.10.3 Sanstar Biopolymers Ltd Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Sanstar Biopolymers Ltd Pharmaceutical Starch Product Portfolio

6.10.5 Sanstar Biopolymers Ltd Recent Developments/Updates

6.11 Ingredion

6.11.1 Ingredion Corporation Information

6.11.2 Ingredion Pharmaceutical Starch Description and Business Overview

6.11.3 Ingredion Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Ingredion Pharmaceutical Starch Product Portfolio

6.11.5 Ingredion Recent Developments/Updates

6.12 Shandong Liujia

6.12.1 Shandong Liujia Corporation Information

6.12.2 Shandong Liujia Pharmaceutical Starch Description and Business Overview

6.12.3 Shandong Liujia Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Shandong Liujia Pharmaceutical Starch Product Portfolio

6.12.5 Shandong Liujia Recent Developments/Updates

6.13 Universal Starch-Chem Allied Ltd

6.13.1 Universal Starch-Chem Allied Ltd Corporation Information

6.13.2 Universal Starch-Chem Allied Ltd Pharmaceutical Starch Description and Business Overview

6.13.3 Universal Starch-Chem Allied Ltd Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Universal Starch-Chem Allied Ltd Pharmaceutical Starch Product Portfolio

6.13.5 Universal Starch-Chem Allied Ltd Recent Developments/Updates

6.14 Hunan Er-Kang Pharmaceutical

6.14.1 Hunan Er-Kang Pharmaceutical Corporation Information

6.14.2 Hunan Er-Kang Pharmaceutical Pharmaceutical Starch Description and Business Overview

6.14.3 Hunan Er-Kang Pharmaceutical Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.14.4 Hunan Er-Kang Pharmaceutical Pharmaceutical Starch Product Portfolio

6.14.5 Hunan Er-Kang Pharmaceutical Recent Developments/Updates

6.15 Jiangxi Yipusheng Pharmaceutical

6.15.1 Jiangxi Yipusheng Pharmaceutical Corporation Information

6.15.2 Jiangxi Yipusheng Pharmaceutical Pharmaceutical Starch Description and Business Overview

6.15.3 Jiangxi Yipusheng Pharmaceutical Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.15.4 Jiangxi Yipusheng Pharmaceutical Pharmaceutical Starch Product Portfolio

6.15.5 Jiangxi Yipusheng Pharmaceutical Recent Developments/Updates

6.16 Shanxi Mr G Pharmaceutical

6.16.1 Shanxi Mr G Pharmaceutical Corporation Information

6.16.2 Shanxi Mr G Pharmaceutical Pharmaceutical Starch Description and Business Overview

6.16.3 Shanxi Mr G Pharmaceutical Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.16.4 Shanxi Mr G Pharmaceutical Pharmaceutical Starch Product Portfolio

6.16.5 Shanxi Mr G Pharmaceutical Recent Developments/Updates

6.17 Shivangan Food & Pharma

6.17.1 Shivangan Food & Pharma Corporation Information

6.17.2 Shivangan Food & Pharma Pharmaceutical Starch Description and Business Overview

6.17.3 Shivangan Food & Pharma Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.17.4 Shivangan Food & Pharma Pharmaceutical Starch Product Portfolio

6.17.5 Shivangan Food & Pharma Recent Developments/Updates

6.18 Splenor Starch LLP

6.18.1 Splenor Starch LLP Corporation Information

6.18.2 Splenor Starch LLP Pharmaceutical Starch Description and Business Overview

6.18.3 Splenor Starch LLP Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.18.4 Splenor Starch LLP Pharmaceutical Starch Product Portfolio

6.18.5 Splenor Starch LLP Recent Developments/Updates

6.19 Weifang Shengtai Medicine

6.19.1 Weifang Shengtai Medicine Corporation Information

6.19.2 Weifang Shengtai Medicine Pharmaceutical Starch Description and Business Overview

6.19.3 Weifang Shengtai Medicine Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.19.4 Weifang Shengtai Medicine Pharmaceutical Starch Product Portfolio

6.19.5 Weifang Shengtai Medicine Recent Developments/Updates

6.20 Taishan Jinantang

6.20.1 Taishan Jinantang Corporation Information

6.20.2 Taishan Jinantang Pharmaceutical Starch Description and Business Overview

6.20.3 Taishan Jinantang Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.20.4 Taishan Jinantang Pharmaceutical Starch Product Portfolio

6.20.5 Taishan Jinantang Recent Developments/Updates

6.21 Anhui Sunhere Pharmaceutical Excipients

6.21.1 Anhui Sunhere Pharmaceutical Excipients Corporation Information

6.21.2 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Starch Description and Business Overview

6.21.3 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Starch Sales, Revenue and Gross Margin (2017-2022)

6.21.4 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Starch Product Portfolio

6.21.5 Anhui Sunhere Pharmaceutical Excipients Recent Developments/Updates

7 Pharmaceutical Starch Manufacturing Cost Analysis

7.1 Pharmaceutical Starch Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Pharmaceutical Starch

7.4 Pharmaceutical Starch Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Pharmaceutical Starch Distributors List

8.3 Pharmaceutical Starch Customers

9 Pharmaceutical Starch Market Dynamics

9.1 Pharmaceutical Starch Industry Trends

9.2 Pharmaceutical Starch Market Drivers

9.3 Pharmaceutical Starch Market Challenges

9.4 Pharmaceutical Starch Market Restraints

10 Global Market Forecast

10.1 Pharmaceutical Starch Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Pharmaceutical Starch by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Pharmaceutical Starch by Type (2023-2028)

10.2 Pharmaceutical Starch Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Pharmaceutical Starch by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Pharmaceutical Starch by Application (2023-2028)

10.3 Pharmaceutical Starch Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Pharmaceutical Starch by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Pharmaceutical Starch by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample